Literature DB >> 22450763

Cellular apoptosis susceptibility (chromosome segregation 1-like, CSE1L) gene is a key regulator of apoptosis, migration and invasion in colorectal cancer.

Ayham Alnabulsi1, Abdelali Agouni, Suman Mitra, Isaac Garcia-Murillas, Brian Carpenter, Steve Bird, Graeme I Murray.   

Abstract

Cellular apoptosis susceptibility (chromosome segregation 1-like, CSE1L) gene maps to chromosomal region 20q13.13, a region frequently amplified in solid tumours. In this study, we investigated the roles played by CSE1L in colorectal cancer by examining CSE1L expression and clinico-pathological parameters in colorectal cancer and investigating the effect of CSE1L on the viability, adhesion and migration of colorectal cancer cells. RT-PCR showed that CSE1L mRNA was over-expressed in colorectal cancer. CSE1L depletion by knock-down with CSE1L-specific siRNA significantly reduced viability in HCT116 cells (p = 0.004) and SW480 cells (p = 0.003) whilst significantly increasing the proportion of apoptotic HCT116 cells (p < 0.001) and SW480 cells (p < 0.001). Furthermore, CSE1L depletion significantly reduced the adhesive capacity of HCT116 (p = 0.003) and SW480 cells (p = 0.004). Analysis by qRT-PCR following CSE1L siRNA treatment of HCT116 and SW480 cells showed significant modulation of key apoptotic (p53, p73 and BAK) and adhesive (E-cadherin, Ep-CAM and ICAM-1) molecules. Immunohistochemistry of a colorectal cancer tissue microarray showed that CSE1L had a significantly increased level in colorectal cancer compared to normal colorectal epithelium (p < 0.001). There were significant decreases in both nuclear (p = 0.006) and cytoplasmic (p = 0.003) staining of CSE1L in tumours with lymph node metastasis (stage 3 tumours) compared with lymph node-negative tumours (stage 1 and 2 tumours). In lymph node-negative patients, poor survival was associated with increased CSE1L cytoplasmic expression (p = 0.042). These results indicate that CSE1L is associated with viability and apoptosis, cellular adhesion and invasion, thus implicating CSE1L in the progression of colorectal cancer.
Copyright © 2012 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Keywords:  adhesion; apoptosis; cellular apoptosis susceptibility gene; chromosome segregation 1-like protein CSE1L; colorectal cancer; invasion; migration; p53

Mesh:

Substances:

Year:  2012        PMID: 22450763     DOI: 10.1002/path.4031

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  16 in total

Review 1.  CAS (CSE1L) signaling pathway in tumor progression and its potential as a biomarker and target for targeted therapy.

Authors:  Ming-Chung Jiang
Journal:  Tumour Biol       Date:  2016-09-05

2.  Knockdown of CSE1L Gene in Colorectal Cancer Reduces Tumorigenesis in Vitro.

Authors:  Jose M Pimiento; Kevin G Neill; Evita Henderson-Jackson; Steven A Eschrich; Dung-Tsa Chen; Kazim Husain; David Shibata; Domenico Coppola; Mokenge P Malafa
Journal:  Am J Pathol       Date:  2016-08-10       Impact factor: 4.307

3.  Expression of CAS/CSE1L, the Cellular Apoptosis Susceptibility Protein, Correlates With Neoplastic Progression in Barrett's Esophagus.

Authors:  Kun Jiang; Kevin Neill; Daniel Cowden; Jason Klapman; Steven Eschrich; José Pimiento; Mokenge P Malafa; Domenico Coppola
Journal:  Appl Immunohistochem Mol Morphol       Date:  2018-09

4.  Roles of the CSE1L-mediated nuclear import pathway in epigenetic silencing.

Authors:  Qiang Dong; Xiang Li; Cheng-Zhi Wang; Shaohua Xu; Gang Yuan; Wei Shao; Baodong Liu; Yong Zheng; Hailin Wang; Xiaoguang Lei; Zhuqiang Zhang; Bing Zhu
Journal:  Proc Natl Acad Sci U S A       Date:  2018-04-10       Impact factor: 11.205

5.  CSE1L, a novel microvesicle membrane protein, mediates Ras-triggered microvesicle generation and metastasis of tumor cells.

Authors:  Ching-Fong Liao; Shu-Hui Lin; Hung-Chang Chen; Cheng-Jeng Tai; Chun-Chao Chang; Li-Tzu Li; Chung-Min Yeh; Kun-Tu Yeh; Ying-Chun Chen; Tsu-Han Hsu; Shing-Chuan Shen; Woan-Ruoh Lee; Jeng-Fong Chiou; Shue-Fen Luo; Ming-Chung Jiang
Journal:  Mol Med       Date:  2012-12-06       Impact factor: 6.354

6.  CSE1L promotes nuclear accumulation of transcriptional coactivator TAZ and enhances invasiveness of human cancer cells.

Authors:  Shunta Nagashima; Junichi Maruyama; Kaori Honda; Yasumitsu Kondoh; Hiroyuki Osada; Makiko Nawa; Ken-Ichi Nakahama; Mari Ishigami-Yuasa; Hiroyuki Kagechika; Haruhiko Sugimura; Hiroaki Iwasa; Kyoko Arimoto-Matsuzaki; Hiroshi Nishina; Yutaka Hata
Journal:  J Biol Chem       Date:  2021-05-20       Impact factor: 5.157

7.  Novel metastatic models of esophageal adenocarcinoma derived from FLO-1 cells highlight the importance of E-cadherin in cancer metastasis.

Authors:  David S Liu; Sanne J M Hoefnagel; Oliver M Fisher; Kausilia K Krishnadath; Karen G Montgomery; Rita A Busuttil; Andrew J Colebatch; Matthew Read; Cuong P Duong; Wayne A Phillips; Nicholas J Clemons
Journal:  Oncotarget       Date:  2016-12-13

8.  Correlations between cytoplasmic CSE1L in neoplastic colorectal glands and depth of tumor penetration and cancer stage.

Authors:  Cheng-Jeng Tai; Tzu-Cheng Su; Ming-Chung Jiang; Hung-Chang Chen; Shing-Chuan Shen; Woan-Ruoh Lee; Ching-Fong Liao; Ying-Chun Chen; Shu-Hui Lin; Li-Tzu Li; Ko-Hung Shen; Chung-Min Yeh; Kun-Tu Yeh; Ching-Hsiao Lee; Hsin-Yi Shih; Chun-Chao Chang
Journal:  J Transl Med       Date:  2013-01-31       Impact factor: 5.531

9.  Inhibition of Nuclear Transport of NF-ĸB p65 by the Salmonella Type III Secretion System Effector SpvD.

Authors:  Nathalie Rolhion; R Christopher D Furniss; Grzegorz Grabe; Aindrias Ryan; Mei Liu; Sophie A Matthews; David W Holden
Journal:  PLoS Pathog       Date:  2016-05-27       Impact factor: 6.823

10.  Quantitative analysis of gene expression in fixed colorectal carcinoma samples as a method for biomarker validation.

Authors:  Beata Ostasiewicz; Paweł Ostasiewicz; Kamila Duś-Szachniewicz; Katarzyna Ostasiewicz; Piotr Ziółkowski
Journal:  Mol Med Rep       Date:  2016-04-27       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.